Abstract:Objectives: Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in China and, due to the limited efficacy of currently available therapies, is responsible for a large number of deaths. IFN-alpha therapy has shown promise in the treatment of various forms of human cancer and is considered in the treatment of HCC. Previous results from our group showed that high doses of IFN-alpha exert a significant antiproliferative effect on MHCC97 human xenografts in nude mice, but not on MHCC97 cells when tested in vitro. Here we present experiments designed to characterize the molecular mechanism underlying the defective response of MHCC97 cells to IFN-alpha. Elucidation of the mechanism underlying the defective response of MHCC97 to IFN-alpha may help to explain and possibly to overcome clinical failures of this form of tumor therapy. Methods: IFN-alpha(2a) was administered between 3,000 and 10,000 IU/ml, a range strongly inhibiting proliferation in other cell lines. Gene expression profiles of MHCC97 cells were obtained before and after treatment with IFN-alpha(2a) using cDNA microarray analysis. The transcriptional activity of relevant genes responding to IFN-alpha(2a) in the cDNA microarray experiments was confirmed by RT-PCR and Northern blot analysis. Transient transfection with an expression vector was used to restore p48-ISGFA (IRF9) protein levels. Cell proliferation was evaluated using the MTT assay. Results: Although IFN-alpha treatment caused the activation of several signal transduction pathways in MHCC97 cells, the lack of an antiproliferative effect was found to mainly derive from a defect in the activation of the transcription factor ISGF3 required for Jak/STATS signaling. We show that the defect in ISGF3 activation is mainly caused by the absence of one of its essential components, the protein p48-ISGFgamma from MHCC97 cells. Indeed, transient expression of p48-ISGFgamma restores sensitivity to IFN-alpha(2a). Although the mRNA levels of p48-ISGFgamma were normal in MHCC97 cells, mutations could be detected in the gene coding for the protein. We hypothesize, therefore, that these mutations alter the message or protein stability, leading to the reduced protein levels observed. Conclusion: Our results confirm the important role of Jak/STATS signaling in the antiproliferative effects of IFN-alpha in tumor cells and indicate that defects in ISGF3 can cause resistance to IFN-alpha(2a) treatment. Copyright (C) 2004 S. Karger AG, Basel.

The Expression of Several Molecules in JAK/STATs Signaling Pathway in MHCC97 Hepatocellular Carcinoma Cells with High Metastatic Potential

Reconstructing the JAK/STATs Signal Pathway Restored the Anti-Proliferative Response of MHCC97 on Interferon Alpha

Modulation of Gene Expression in MHCC97 Cells by Interferon Alpha

Reduction in P48-Isgfgamma Levels Confers Resistance to Interferon-Alpha2a in MHCC97 Cells.

Reduction in p48-ISGFγ Levels Confers Resistance to Interferon-α<sub>2a</sub> in MHCC97 Cells

STAT1 Inhibits Human Hepatocellular Carcinoma Cell Growth Through Induction of P53 and Fbxw7

Interferon-α Significantly Inhibits the Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Expression in the Hepatocellular Carcinoma of Nude Mice Model with Highly Metastatic Potential

Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

Hypoxia-inducible Factor-1 Signaling Pathway Influences the Sensitivity of HCC827 Cells to Gefitinib.

Direct Transformation of Lung Microenvironment by Interferon-Α Treatment Counteracts Growth of Lung Metastasis of Hepatocellular Carcinoma.

Mechanism of Interferon Alpha on Inhibition of Metastasis and Angiogenesis of Hepatocellular Carcinoma after Curative Resection in Nude Mice

Interferon-α Combined with Herbal Compound "songyou Yin" Effectively Inhibits the Increased Invasiveness and Metastasis by Insufficient Radiofrequency Ablation of Hepatocellular Carcinoma in an Animal Model.

Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma

[Interferon-Alpha Upregulates Thymidine Phosphorylase Expression Via JAK-STAT Transcriptional Activation and Mrna Stabilization in Human Hepatocellular Carcinoma SMMC-7721 Cells].

Long-term Interferon-Α Treatment Suppresses Tumor Growth but Promotes Metastasis Capacity in Hepatocellular Carcinoma.

The Role and Mechanism of Low-Dose Aspirin with IFN-α in Inhibiting Growth and Metastasis of Hepatocellular Carcinoma

Expression and Biological Mechanism Exploration of Hsp27 in Different Metastatic Hcc Cell Lines

Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells.

Long-Term Interferon-Alpha Treatment Suppresses Tumor Growth But Promotes Metastasis Capacity In Hepatocellular Carcinoma

Effect of Specific Inhibition of JAK/STAT3 Signaling Pathway on Hepatocellular Carcinoma in Rats

Expression of X-Linked Inhibitor-Of-Apoptosis Protein in Hepatocellular Carcinoma Promotes Metastasis and Tumor Recurrence